Dr. Ahmed is the President and CSO of VITRUVIAE, a privately held biotechnology company developing pan-agents for cancer, infectious diseases, and mental illness. He was formerly the SVP and CSO of Y-mAbs Therapeutics, a commercial and clinical stage public biotechnology company, and a faculty member in the Department of Pediatrics at Memorial Sloan Kettering Cancer Center. Dr. Ahmed is an expert in computational drug design and protein engineering. He received his PhD in Biochemistry and Structural Biology from Stony Brook University, followed by post-doctoral training in cancer immunology at Memorial Sloan Kettering.
